North Chicago Business
-
Abbott gets FDA OK for second antibody testMay 11, 2020 1:00 am - Abbott Laboratories has received emergency authorization from the Food and Drug Administration to produce a second COVID-19 antibody test. The North Chicago-based medica...
-
Abbott launches COVID-19 test that focuses on antibodiesApr 15, 2020 1:00 am - Abbott Laboratories said Wednesday it is launching a third COVID-19 test, this time focusing on antibodies the company said could support the development of treatments a...
-
Virus hot spots clamor for Abbott's quick testsApr 02, 2020 1:00 am - As Abbott Laboratories began shipping its new rapid-response tests across the country Wednesday, a new flashpoint emerged in the nation's handling of the pandemic: where...
-
Early coronavirus drug trials yield mixed resultsMar 19, 2020 1:00 am - Drug trials on coronavirus patients in China yielded mixed results, with an HIV pill showing little benefit and a flu medication made by Fujifilm Holdings Corp. resultin...
-
Abbott gets emergency OK to ship COVID-19 test kits, ramps up productionMar 19, 2020 1:00 am - Abbott has received emergency use authorization from the Food and Drug Administration to ship its COVID-19 test kits, the company announced Thursday. The North Chicago-b...
-
An equal share of legal pot: Entrepreneurs look to communities hurt by laws in the pastDec 10, 2019 4:00 am - When Illinois begins accepting applications today from the general public to open recreational marijuana stores, Zuly Gomez and Alexander Perez hope they'll have an edge...
-
Abbott inks partnership for diabetes systemOct 16, 2019 1:00 am - North Chicago-based Abbott announced it has established a partnership with Omada Health, which will integrate Abbott's Freestyle Libre Type 2 diabetes monitoring system ...
-
AbbVie ends work on cancer drug after failuresAug 29, 2019 1:00 am - AbbVie Inc. said it would stop all research on its experimental cancer treatment Rova-T, a drug it bought in its $5.8 billion 2016 takeover of Stemcentrx Inc. The decisi...
-
AbbVie ends work on cancer drug Rova-T after failuresAug 29, 2019 1:00 am - AbbVie Inc. said it would stop all research on its experimental cancer treatment Rova-T, a drug it bought in its $5.8 billion 2016 takeover of Stemcentrx Inc. The decisi...
-
Constable: Scientist sees genomes as 'blueprint' for treatmentJun 29, 2019 1:00 am - Ten years ago, 4-year-old Nicholas Volker of Wisconsin had exhausted treatment options for his digestive issues. "Nic was dying, and no one knew why," remembers Howard J...